Webinar: ACR/CHEST ILD Guidelines in Practice| Video: All the Lonely People

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Studies Highlight Gender, Racial Inequalities in Medical Profession

Andrew M. Seaman  |  

(Reuters Health)—Women and minorities face more barriers to getting ahead in their medical careers, both early in training and later on, researchers say. In one study, Dr. Julie Boiko of the University of California, San Francisco, and colleagues found that women are underrepresented among speakers at grand rounds. This was true for all but two…

Trump Backs House Healthcare Plan, Says Open to Negotiations

Reuters Staff  |  

WASHINGTON (Reuters)—U.S. President Donald Trump on Tuesday backed a draft Republican proposal to dismantle Obamacare that was unveiled Monday, saying the proposed healthcare legislation was “out for review and negotiation.” Trump, in a tweet on Tuesday morning, described the bill proposed by fellow Republicans in the House of Representatives as “Our wonderful new healthcare bill.”…

U.S. Republicans Unveil Plan to Dismantle Obamacare, Critics Pounce

Susan Cornwell & Yasmeen Abutaleb  |  

WASHINGTON (Reuters)—Long-awaited legislation to dismantle Obamacare was unwrapped on Monday by U.S. Republicans, who called for ending health insurance mandates and rolling back extra healthcare funding for the poor in a package that drew immediate fire from Democrats. In a battle waged since the 2010 passage of the Affordable Care Act, Democratic President Barack Obama’s…

U.S. Republicans Expected to Unveil Healthcare Bill This Week

Susan Cornwell  |  

WASHINGTON (Reuters)—Republican U.S. lawmakers expect to unveil this week the text of long-awaited legislation to repeal and replace the Obamacare healthcare law, one of President Donald Trump’s top legislative priorities, a senior Republican congressional aide said on Sunday. Since taking office in January, Trump has pressed his fellow Republicans who control Congress to act quickly…

Infliximab Use Not Tied to Malignancy in Pediatric IBD

David Douglas  |  

NEW YORK (Reuters Health)—Immunosuppressive therapy with infliximab (Remicade) for inflammatory bowel disease (IBD) in pediatric patients is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis (HLH), according to a Janssen study. Dr. Jeffrey S. Hyams, who worked on the study, calls the finding “reassuring.” He adds in an email to Reuters Health, “our…

Industry Ties Common among Nonprofit Patient Advocacy Groups

Gene Emery  |  

(Reuters Health)—An examination of more than 100 of the largest U.S. nonprofit organizations created to improve health and fight disease has found that more than 8 in 10 get financial support from companies involved in the drug, biotechnology and medical device industry. In addition, over a third have at least one industry official on their…

A New Administration Brings Updated ACR Policy Positions

  |  

The ACR continues to broaden its advocacy efforts on issues critical to rheumatology, as described in updates to its 2017 health policy statements. Along with continuing to advocate for access to care and treatments, enhancements to rheumatology research and training the next generation of rheumatologists, the 2017 health policy statements address a number of new…